Featured Commentary: What a difference a year makes: 1 year after implementing the AHRQ National Guideline Clearinghouse’s revised inclusion criteria.
This month’s GROWTH Commentary is the second in a series reflecting on the past 4 years since the landmark IOM reports on Clinical Practice Guidelines We Can Trust and Finding What Works in Health Care: Standards for Systematic Reviews were published. Last month, Sheldon Greenfield, MD, Chair of the first of these mused about the state of guidelines and guideline development today, areas of progress and areas that could continue to improve. This month, Mary Nix, MS, PMP, Staff Lead of the AHRQ National Guidelines Clearinghouse (NGC), discusses the NGC inclusion criteria that were revamped as a result of recommendations from the IOM report and how the revised criteria have impacted the submissions of guidelines. In subsequent months, we will have commentaries reflecting on changes felt by guideline developers and how the IOM reports affected patient engagement.
Doctor Evidence is now a content provider for IBM Watson, contributing clinical oncology research evidence for Watson’s healthcare ecosystem. Through this special arrangement, developers can create medical apps utilizing data provided by Doctor Evidence’s unique Digital Outcome Conversion technologies.
Doctor Evidence is proud to again help sponsor the annual
Guidelines International Network (G-I-N) conference
October 7-10, 2015, in Amsterdam.
The G-I-N 2015 conference theme is, "Engaging all stakeholders. Guidelines from a societal perspective.” Stakeholders in guidelines are patients, consumers, health care professionals, policy makers, purchasers of care, health insurers, federal and local health authorities, guideline developers and researchers.
Early bird discount registration ends July 8, 2015, so register today!
For more information and to register, visit the conference website athttp://www.gin2015.net/
Upcoming Commentaries: June 2015
The GROWTH Commentary
is designed to be interactive.
To login follow these simple steps:
1. User name: enter your email address
2. Password: enter the word "commentaries"
If you were forwarded this email please follow the new “Register here” steps.